Journal article · 2022 · Open access
Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo
Nature Communications, 13(1), 4766 · Published 15 August 2022 · DOI 10.1038/s41467-022-32281-5
In brief
“Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo” is a 2022 journal article by Huanzhen Ni and 10 co-authors, published in Nature Communications. OpenAlex counts 208 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Nature Communications.
- Citations
- 208
- Most cited in
- 2025 (61)
- Field-weighted impact
- 10.36
- References
- 53
- Authors
- 11
Abstract
In humans, lipid nanoparticles (LNPs) have safely delivered therapeutic RNA to hepatocytes after systemic administration and to antigen-presenting cells after intramuscular injection. However, systemic RNA delivery to non-hepatocytes remains challenging, especially without targeting ligands such as antibodies, peptides, or aptamers. Here we report that piperazine-containing ionizable lipids (Pi-Lipids) preferentially deliver mRNA to immune cells in vivo without targeting ligands. After synthesizing and characterizing Pi-Lipids, we use high-throughput DNA barcoding to quantify how 65 chemically distinct LNPs functionally delivered mRNA (i.e., mRNA translated into functional, gene-editing protein) in 14 cell types directly in vivo. By analyzing the relationships between lipid structure and cellular targeting, we identify lipid traits that increase delivery in vivo. In addition, we characterize Pi-A10, an LNP that preferentially delivers mRNA to the liver and splenic immune cells at the clinically relevant dose of 0.3 mg/kg. These data demonstrate that high-throughput in vivo studies can identify nanoparticles with natural non-hepatocyte tropism and support the hypothesis that lipids with bioactive small-molecule motifs can deliver mRNA in vivo.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ni, H., Hatit, M. Z. C., Zhao, K., Loughrey, D., Lokugamage, M. P., Peck, H. E., Del Cid, A., Muralidharan, A., Kim, Y., Santangelo, P. J., & Dahlman, J. E. (2022). Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo. Nature Communications, 13(1), 4766. https://doi.org/10.1038/s41467-022-32281-5
MLA 9
Ni, Huanzhen, et al. “Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo.” Nature Communications, vol. 13, no. 1, 2022, p. 4766. https://doi.org/10.1038/s41467-022-32281-5.
Chicago
Ni, Huanzhen, Marine Z. C. Hatit, Kun Zhao, David Loughrey, Melissa P. Lokugamage, Hannah E. Peck, Ada Del Cid, et al. 2022. “Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo.” Nature Communications 13 (1): 4766. https://doi.org/10.1038/s41467-022-32281-5.
Harvard
Ni, H. et al. (2022) ‘Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo’, Nature Communications, 13(1), p. 4766. doi:10.1038/s41467-022-32281-5.
IEEE
H. Ni et al., “Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo,” Nature Communications, vol. 13, no. 1, p. 4766, 2022, doi: 10.1038/s41467-022-32281-5.
BibTeX
@article{ni2022piperazine,
title = {{Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo}},
author = {Ni, Huanzhen and Hatit, Marine Z. C. and Zhao, Kun and Loughrey, David and Lokugamage, Melissa P. and Peck, Hannah E. and Del Cid, Ada and Muralidharan, Abinaya and Kim, YongTae and Santangelo, Philip J. and Dahlman, James E.},
journal = {Nature Communications},
year = {2022},
volume = {13},
number = {1},
pages = {4766},
doi = {10.1038/s41467-022-32281-5},
url = {https://doi.org/10.1038/s41467-022-32281-5}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 1 | |
| 2023 | 35 | |
| 2024 | 55 | |
| 2025 | 61 | |
| 2026 | 56 |
Its field-weighted citation impact is 10.36: it has been cited 10.36 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- lipid nanoparticles
- mRNA delivery
- immune cells
- splenic B cells
- liver targeting
- DNA barcoding
- in vivo delivery
- genome editing
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Ni, H., Hatit, M. Z. C., Zhao, K., Loughrey, D., Lokugamage, M. P., Peck, H. E., Del Cid, A., Muralidharan, A., Kim, Y., Santangelo, P. J., & Dahlman, J. E. (2022). Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo. Nature Communications, 13(1), 4766. https://doi.org/10.1038/s41467-022-32281-5
How many times has this paper been cited?
208 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Nature Communications: sign in and open the PDF from this page.
Who wrote this paper?
Huanzhen Ni, Marine Z. C. Hatit, Kun Zhao, David Loughrey, Melissa P. Lokugamage, Hannah E. Peck, Ada Del Cid, Abinaya Muralidharan, YongTae Kim, Philip J. Santangelo, James E. Dahlman.
What is the DOI of this paper?
10.1038/s41467-022-32281-5, permanently at https://doi.org/10.1038/s41467-022-32281-5. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.